Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis (Cancer-DACUS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by Azienda Ospedaliera Universitaria Policlinico.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Azienda Ospedaliera Universitaria Policlinico
ClinicalTrials.gov Identifier:
NCT00450645
First received: March 20, 2007
Last updated: March 3, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2011
  Estimated Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)